Biomarkers of age effect on renal function in Down syndrome

References

• Alessio L, Berlin A, Dell’Orto A, Toffoletto F, Ghezzi I. (1985). Reliability of urinary creatinine as a parameter used to adjust values of urinary biological indicators. Int Arch Occup Environ Health 55:99–106.
   PubMed Web of Science ®Google Scholar
• Allison DB, Gomez JE, Heshka S, Babbitt RL, Geliebter A, Kreibich K, Heymsfield SB. (1995). Decreased resting metabolic rate among persons with Down Syndrome. Int J Obes Relat Metab Disord 19:858–861.
   PubMed Web of Science ®Google Scholar
• Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. (2005). Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 113:192–200.
   PubMed Web of Science ®Google Scholar
• Bittles AH, Bower C, Hussain R, Glasson EJ. (2007). The four ages of Down syndrome. Eur J Public Health 17:221–225.
   PubMed Web of Science ®Google Scholar
• Boeniger MF, Lowry LK, Rosenberg J. (1993). Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: a review. Am Ind Hyg Assoc J 54:615–627.
   PubMed Web of Science ®Google Scholar
• Campos C, Guzmán R, López-Fernández E, Casado A. (2011). Evaluation of urinary biomarkers of oxidative/nitrosative stress in adolescents and adults with Down syndrome. Biochim Biophys Acta 1812:760–768.
   PubMed Web of Science ®Google Scholar
• Carrieri M, Trevisan A, Bartolucci GB. (2001). Adjustment to concentration-dilution of spot urine samples: correlation between specific gravity and creatinine. Int Arch Occup Environ Health 74:63–67.
   PubMed Web of Science ®Google Scholar
• Coburn SP, Seidenberg M, Mertz ET. (1967). Clearance of uric acid, urea, and creatinine in Down’s syndrome. J Appl Physiol 23:579–580.
   PubMedGoogle Scholar
• Coppus AM, Evenhuis HM, Verberne GJ, Visser FE, Eikelenboom P, van Gool WA, Janssens AC, van Duijn CM. (2010). Early age at menopause is associated with increased risk of dementia and mortality in women with Down syndrome. J Alzheimers Dis 19:545–550.
   Google Scholar
• Dowjat WK, Adayev T, Kuchna I, Nowicki K, Palminiello S, Hwang YW, Wegiel J. (2007). Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome. Neurosci Lett 413:77–81.
   PubMed Web of Science ®Google Scholar
• Down JLH. (1866). Observations on an ethnic classification of idiots. Clinical Lecture Reports, London Hospital. 3:259–262.
   Google Scholar
• Fernhall B, Figueroa A, Collier S, Goulopoulou S, Giannopoulou I, Baynard T. (2005). Resting metabolic rate is not reduced in obese adults with Down syndrome. Ment Retard 43:391–400.
   Google Scholar
• Forbes GB, Bruining GJ. (1976). Urinary creatinine excretion and lean body mass. Am J Clin Nutr 29:1359–1366.
   PubMed Web of Science ®Google Scholar
• Fort P, Lifshitz F, Bellisario R, Davis J, Lanes R, Pugliese M, Richman R, Post EM, David R. (1984). Abnormalities of thyroid function in infants with Down syndrome. J Pediatr 104:545–549.
   PubMed Web of Science ®Google Scholar
• Gupta SK, Venkataseshan VS, Churg J. (1991). Mesangiocapillary glomerulonephritis in Down’s syndrome. Am J Nephrol 11:112–117.
   Google Scholar
• Hoberman HD, Sims EA, Peters JH. (1948). Creatine and creatinine metabolism in the normal male adult studied with the aid of isotopic nitrogen. J Biol Chem 172:45–58.
   PubMed Web of Science ®Google Scholar
• Hook EB. (1981). Down’s syndrome-frequency in human populations and factors pertinent to variation in rates. In: de la Cruzz FF, Gerald PS, editors. Trisomy 21 (Down syndrome): research perspectives. Baltimore: University Park Press; p. 3–68.
   Google Scholar
• Hook EG. (1982). Epidemiology of Down syndrome. In: Pueschel SM, Rynders JE, editors. Down syndrome Advances in biomedicine and Behavioral Sciences. Cambridge, Massachusetts: Ware Press.
   Google Scholar
• Jaffé M. (1986). Über den niederschlag, welchen pikrinsäure in normalen harn erzeugt und über eine neue reaktion des kreatinins. Z Physiol Chem 10:391–400.
   Google Scholar
• Kavouras SA. (2002). Assessing hydration status. Curr Opin Clin Nutr Metab Care 5:519–524.
   PubMed Web of Science ®Google Scholar
• Keshaviah PR, Nolph KD, Moore HL, Prowant B, Emerson PF, Meyer M, Twardowski ZJ, Khanna R, Ponferrada L, Collins A. (1994). Lean body mass estimation by creatinine kinetics. J Am Soc Nephrol 4:1475–1485.
   PubMedGoogle Scholar
• Korsager S, Chatham EM, Ostergaard Kristensen HP. (1978). Thyroid function tests in adults with Down’s syndrome. Acta Endocrinol 88:48–54.
   PubMedGoogle Scholar
• Lafayette RA, Costa ME, King AJ. (1994). Increased serum creatinine in the absence of renal failure in profound hypothyroidism. Am J Med 96:298–299.
   PubMedGoogle Scholar
• Lejeune J, Gautier M, Turpin R. (1959). Etude des chromosomes somatiques de neuf enfants mongoliens. CR Hebd Acad Sci 248:1721–1722.
   PubMed Web of Science ®Google Scholar
• Lott IT, Lai F. (1982). Dementia in Down’s syndrome: observations from a neurology clinic. Appl Res Ment Retard 3:233–239.
   PubMedGoogle Scholar
• Luke A, Sutton M, Schoeller DA, Roizen NJ. (1996). Nutrient intake and obesity in prepubescent children with Down syndrome. J Am Diet Assoc 96:1262–1267.
   PubMedGoogle Scholar
• Málaga S, Pardo R, Málaga I, Orejas G, Fernández-Toral J. (2005). Renal involvement in Down syndrome. Pediatr Nephrol 20:614–617.
   Google Scholar
• Mercer ES, Broecker B, Smith EA, Kirsch AJ, Scherz HC, A Massad C. (2004). Urological manifestations of Down syndrome. J Urol 171:1250–1253.
   Google Scholar
• Montenegro J, González O, Saracho R, Aguirre R, González O, Martínez I. (1996). Changes in renal function in primary hypothyroidism. Am J Kidney Dis 27:195–198.
   PubMed Web of Science ®Google Scholar
• Musso CG, Macías Nuñez JF, Oreopoulos DG. (2007). Physiological similarities and differences between renal aging and chronic renal disease. J Nephrol 20:586–587.
   PubMed Web of Science ®Google Scholar
• Musso CG, Michelángelo H, Vilas M, Reynaldi J, Martinez B, Algranati L, Macías Núñez JF. (2009). Creatinine reabsorption by the aged kidney. Int Urol Nephrol 41:727–731.
   PubMed Web of Science ®Google Scholar
• Musso CG, Oreopoulos DG. (2011). Aging and physiological changes of the kidneys including changes in glomerular filtration rate. Nephron Physiol 119 Suppl 1:p1–p5.
   Google Scholar
• Nève J, Sinet PM, Molle L, Nicole A. (1983). Selenium, zinc and copper in Down’s syndrome (trisomy 21): blood levels and relations with glutathione peroxidase and superoxide dismutase. Clin Chim Acta 133:209–214.
   Google Scholar
• Nishida Y, Akaoka I, Kobayashi M, Maruki K, Oshima Y. (1979). Renal impairment in urate excretion in patients with Down’s syndrome. J Rheumatol 6:103–107.
   Google Scholar
• Nyman U, Björk J, Sterner G, Bäck SE, Carlson J, Lindström V, Bakoush O, Grubb A. (2006). Standardization of p-creatinine assays and use of lean body mass allow improved prediction of calculated glomerular filtration rate in adults: a new equation. Scand J Clin Lab Invest 66:451–468.
   PubMed Web of Science ®Google Scholar
• Remer T, Neubert A, Maser-Gluth C. (2002). Anthropometry-based reference values for 24-h urinary creatinine excretion during growth and their use in endocrine and nutritional research. Am J Clin Nutr 75:561–569.
   PubMed Web of Science ®Google Scholar
• Rubin SS, Rimmer JH, Chicoine B, Braddock D, McGuire DE. (1998). Overweight prevalence in persons with Down syndrome. Ment Retard 36:175–181.
   PubMedGoogle Scholar
• Shaposhnikov AM, Khal’chitskii SE, Shvarts EI. (1979). Disorders of phenylalanine and tyrosine metabolism in Down’s syndrome. Vopr Med Khim 25:15–19.
   Google Scholar
• Suwazono Y, Akesson A, Alfvén T, Järup L, Vahter M. (2005). Creatinine versus specific gravity-adjusted urinary cadmium concentrations. Biomarkers 10:117–126.
   PubMed Web of Science ®Google Scholar
• Tórsdóttir G, Kristinsson J, Hreidarsson S, Snaedal J, Jóhannesson T. (2001). Copper, ceruloplasmin and superoxide dismutase (SOD1) in patients with Down’s syndrome. Pharmacol Toxicol 89:320–325.
   Google Scholar
• Van Buggenhout GJ, Trommelen JC, Schoenmaker A, De Bal C, Verbeek JJ, Smeets DF, Ropers HH, Devriendt K, Hamel BC, Fryns JP. (1999). Down syndrome in a population of elderly mentally retarded patients: genetic-diagnostic survey and implications for medical care. Am J Med Genet 85:376–384.
   PubMed Web of Science ®Google Scholar
• van Trotsenburg AS, Vulsma T, van Rozenburg-Marres SL, van Baar AL, Ridder JC, Heymans HS, Tijssen JG, de Vijlder JJ. (2005). The effect of thyroxine treatment started in the neonatal period on development and growth of two-year-old Down syndrome children: a randomized clinical trial. J Clin Endocrinol Metab 90:3304–3311.
   Web of Science ®Google Scholar
• Varley H, Gowenlock AH, Bell M. 1980. Non-protein nitrogen, urea, urate, creatine and creatinine. Practical Clinical Biochemistry. London: William Heinemann Medical Books Ltd.; p. 484–485.
   Google Scholar
• Voinescu GC, Shoemaker M, Moore H, Khanna R, Nolph KD. (2002). The relationship between urine osmolality and specific gravity. Am J Med Sci 323:39–42.
   Google Scholar
• Wiggins J. (2011). Why do our kidneys get old? Nephron Exp Nephrol 119 Suppl 1:e1–e5.
   Google Scholar
• Wyss M, Kaddurah-Daouk R. (2000). Creatine and creatinine metabolism. Physiol Rev 80:1107–1213.
   PubMed Web of Science ®Google Scholar